MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.
3 reports, 2 independent
Updated Tue 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Leerink, Morgan Stanley, Truist, and MarketBeat issued new ratings/targets for Cytokinetics.1 source
Cytokinetics receives analyst rating updates from BofA and Morgan Stanley, tracked by MarketBeat.1 source
Keep exploring
The entities involved
-
Cytokinetics
company in South San Francisco, United States
-
MarketBeat
American personal finance blog
-
Morgan Stanley
U.S. investment bank
Related events
- MarketBeat provided consensus rating data for Colony Bankcorp, Inc.
- MarketBeat provided stock average ratings while Leerink Partners upgraded and Barclays raised its price objective for Summit Therapeutics.
- Scotiabank reissued an outperform rating on Montage Gold, while MarketBeat provided consensus rating data.
- Royal Bank of Canada reaffirmed an outperform rating for Visa Inc., with average rating data provided by MarketBeat.
- MarketBeat, Royal Bank of Canada, and Raymond James Financial updated their ratings and price targets for CT Real Estate Investment Trust.